SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019134
Filing Date
2016-05-12
Accepted
2016-05-11 18:16:10
Documents
35
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gbim-10q_20160331.htm 10-Q 1070976
2 EX-10.2 gbim-ex102_260.htm EX-10.2 26456
3 EX-31.1 gbim-ex311_12.htm EX-31.1 16743
4 EX-31.2 gbim-ex312_8.htm EX-31.2 16762
5 EX-32.1 gbim-ex321_6.htm EX-32.1 6434
  Complete submission text file 0001564590-16-019134.txt   2437974

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gbim-20160331.xml EX-101.INS 284438
7 XBRL TAXONOMY EXTENSION SCHEMA gbim-20160331.xsd EX-101.SCH 18780
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbim-20160331_cal.xml EX-101.CAL 24709
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbim-20160331_def.xml EX-101.DEF 35630
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbim-20160331_lab.xml EX-101.LAB 121784
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbim-20160331_pre.xml EX-101.PRE 96056
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 3036252744
GLOBEIMMUNE INC (Filer) CIK: 0001245104 (see all company filings)

IRS No.: 841353925 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35642 | Film No.: 161641125
SIC: 2834 Pharmaceutical Preparations